nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—ACE—renal artery—nephrolithiasis	0.104	0.41	CbGeAlD
Trandolapril—ACE—nephron—nephrolithiasis	0.0363	0.143	CbGeAlD
Trandolapril—ACE—urine—nephrolithiasis	0.0291	0.115	CbGeAlD
Trandolapril—Blood potassium increased—Hydrochlorothiazide—nephrolithiasis	0.0228	0.0501	CcSEcCtD
Trandolapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC3A1—nephrolithiasis	0.0189	0.0647	CbGpPWpGaD
Trandolapril—Arrhythmia supraventricular—Hydrochlorothiazide—nephrolithiasis	0.0178	0.039	CcSEcCtD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC3A1—nephrolithiasis	0.0175	0.06	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.0122	0.0416	CbGpPWpGaD
Trandolapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC7A9—nephrolithiasis	0.0119	0.0406	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.0113	0.0386	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.0111	0.0381	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.0111	0.0381	CbGpPWpGaD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC7A9—nephrolithiasis	0.011	0.0377	CbGpPWpGaD
Trandolapril—SLC15A1—nephron tubule—nephrolithiasis	0.0109	0.0432	CbGeAlD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.0103	0.0353	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.0103	0.0353	CbGpPWpGaD
Trandolapril—SLC15A1—renal system—nephrolithiasis	0.00993	0.0393	CbGeAlD
Trandolapril—SLC15A1—kidney—nephrolithiasis	0.0096	0.0379	CbGeAlD
Trandolapril—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.00955	0.021	CcSEcCtD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.00843	0.0289	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC2A9—nephrolithiasis	0.00814	0.0279	CbGpPWpGaD
Trandolapril—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.00784	0.0172	CcSEcCtD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.00783	0.0268	CbGpPWpGaD
Trandolapril—ACE—nephron tubule—nephrolithiasis	0.00783	0.031	CbGeAlD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.00782	0.0268	CbGpPWpGaD
Trandolapril—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00742	0.0163	CcSEcCtD
Trandolapril—Gout—Hydrochlorothiazide—nephrolithiasis	0.00738	0.0162	CcSEcCtD
Trandolapril—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00728	0.016	CcSEcCtD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.00727	0.0249	CbGpPWpGaD
Trandolapril—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00719	0.0158	CcSEcCtD
Trandolapril—ACE—renal system—nephrolithiasis	0.00712	0.0281	CbGeAlD
Trandolapril—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00706	0.0155	CcSEcCtD
Trandolapril—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00701	0.0154	CcSEcCtD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.00698	0.0239	CbGpPWpGaD
Trandolapril—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00689	0.0151	CcSEcCtD
Trandolapril—ACE—kidney—nephrolithiasis	0.00688	0.0272	CbGeAlD
Trandolapril—SLC15A2—nephron tubule—nephrolithiasis	0.00683	0.027	CbGeAlD
Trandolapril—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00677	0.0149	CcSEcCtD
Trandolapril—ACE—cortex of kidney—nephrolithiasis	0.0067	0.0265	CbGeAlD
Trandolapril—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.0065	0.0143	CcSEcCtD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.00648	0.0222	CbGpPWpGaD
Trandolapril—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00623	0.0137	CcSEcCtD
Trandolapril—SLC15A2—renal system—nephrolithiasis	0.00621	0.0245	CbGeAlD
Trandolapril—SLC15A2—kidney—nephrolithiasis	0.006	0.0237	CbGeAlD
Trandolapril—SLC15A2—cortex of kidney—nephrolithiasis	0.00585	0.0231	CbGeAlD
Trandolapril—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00577	0.0127	CcSEcCtD
Trandolapril—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00569	0.0125	CcSEcCtD
Trandolapril—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00569	0.0125	CcSEcCtD
Trandolapril—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00554	0.0122	CcSEcCtD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00543	0.0186	CbGpPWpGaD
Trandolapril—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00539	0.0118	CcSEcCtD
Trandolapril—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00534	0.0117	CcSEcCtD
Trandolapril—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0053	0.0116	CcSEcCtD
Trandolapril—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00527	0.0116	CcSEcCtD
Trandolapril—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00514	0.0113	CcSEcCtD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00504	0.0173	CbGpPWpGaD
Trandolapril—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00502	0.011	CcSEcCtD
Trandolapril—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.005	0.011	CcSEcCtD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00497	0.017	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00497	0.017	CbGpPWpGaD
Trandolapril—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00496	0.0109	CcSEcCtD
Trandolapril—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00492	0.0108	CcSEcCtD
Trandolapril—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00468	0.0103	CcSEcCtD
Trandolapril—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00462	0.0101	CcSEcCtD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00461	0.0158	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00461	0.0158	CbGpPWpGaD
Trandolapril—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00458	0.0101	CcSEcCtD
Trandolapril—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00452	0.00993	CcSEcCtD
Trandolapril—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0045	0.00989	CcSEcCtD
Trandolapril—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0045	0.00989	CcSEcCtD
Trandolapril—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00442	0.00972	CcSEcCtD
Trandolapril—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00441	0.00969	CcSEcCtD
Trandolapril—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00435	0.00956	CcSEcCtD
Trandolapril—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00424	0.00931	CcSEcCtD
Trandolapril—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00421	0.00925	CcSEcCtD
Trandolapril—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00888	CcSEcCtD
Trandolapril—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00402	0.00882	CcSEcCtD
Trandolapril—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00399	0.00877	CcSEcCtD
Trandolapril—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00398	0.00875	CcSEcCtD
Trandolapril—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00867	CcSEcCtD
Trandolapril—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0039	0.00857	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00839	CcSEcCtD
Trandolapril—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0038	0.00835	CcSEcCtD
Trandolapril—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00832	CcSEcCtD
Trandolapril—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00378	0.0083	CcSEcCtD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00377	0.0129	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00377	0.0129	CbGpPWpGaD
Trandolapril—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00374	0.00823	CcSEcCtD
Trandolapril—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00369	0.00812	CcSEcCtD
Trandolapril—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00363	0.00799	CcSEcCtD
Trandolapril—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00359	0.0079	CcSEcCtD
Trandolapril—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00352	0.00774	CcSEcCtD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0035	0.012	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0035	0.012	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00349	0.012	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00349	0.012	CbGpPWpGaD
Trandolapril—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00347	0.00762	CcSEcCtD
Trandolapril—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00346	0.0076	CcSEcCtD
Trandolapril—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00343	0.00754	CcSEcCtD
Trandolapril—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00749	CcSEcCtD
Trandolapril—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00333	0.00732	CcSEcCtD
Trandolapril—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00327	0.00719	CcSEcCtD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00325	0.0111	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00325	0.0111	CbGpPWpGaD
Trandolapril—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00322	0.00709	CcSEcCtD
Trandolapril—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00321	0.00705	CcSEcCtD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00312	0.0107	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0031	0.0106	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0031	0.0106	CbGpPWpGaD
Trandolapril—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00309	0.00679	CcSEcCtD
Trandolapril—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00306	0.00672	CcSEcCtD
Trandolapril—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00297	0.00652	CcSEcCtD
Trandolapril—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00295	0.00648	CcSEcCtD
Trandolapril—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00291	0.0064	CcSEcCtD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.0029	0.00992	CbGpPWpGaD
Trandolapril—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00289	0.00636	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00287	0.00984	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00287	0.00984	CbGpPWpGaD
Trandolapril—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00279	0.00614	CcSEcCtD
Trandolapril—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00278	0.00612	CcSEcCtD
Trandolapril—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00277	0.00608	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00276	0.00945	CbGpPWpGaD
Trandolapril—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00275	0.00605	CcSEcCtD
Trandolapril—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00271	0.00597	CcSEcCtD
Trandolapril—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0027	0.00594	CcSEcCtD
Trandolapril—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0027	0.00593	CcSEcCtD
Trandolapril—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00592	CcSEcCtD
Trandolapril—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00266	0.00585	CcSEcCtD
Trandolapril—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00265	0.00582	CcSEcCtD
Trandolapril—Cough—Hydrochlorothiazide—nephrolithiasis	0.00263	0.00577	CcSEcCtD
Trandolapril—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00563	CcSEcCtD
Trandolapril—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00563	CcSEcCtD
Trandolapril—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00563	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00256	0.00877	CbGpPWpGaD
Trandolapril—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00255	0.00561	CcSEcCtD
Trandolapril—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00253	0.00557	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00252	0.00865	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00252	0.00865	CbGpPWpGaD
Trandolapril—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00251	0.00551	CcSEcCtD
Trandolapril—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00246	0.0054	CcSEcCtD
Trandolapril—Shock—Hydrochlorothiazide—nephrolithiasis	0.00242	0.00531	CcSEcCtD
Trandolapril—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00241	0.00529	CcSEcCtD
Trandolapril—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0024	0.00527	CcSEcCtD
Trandolapril—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00238	0.00522	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00234	0.00803	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00234	0.00803	CbGpPWpGaD
Trandolapril—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00234	0.00515	CcSEcCtD
Trandolapril—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0023	0.00505	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00224	0.00492	CcSEcCtD
Trandolapril—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00222	0.00488	CcSEcCtD
Trandolapril—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00221	0.00485	CcSEcCtD
Trandolapril—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00219	0.00481	CcSEcCtD
Trandolapril—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00218	0.0048	CcSEcCtD
Trandolapril—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00216	0.00475	CcSEcCtD
Trandolapril—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00214	0.00469	CcSEcCtD
Trandolapril—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00212	0.00466	CcSEcCtD
Trandolapril—Constipation—Hydrochlorothiazide—nephrolithiasis	0.0021	0.00462	CcSEcCtD
Trandolapril—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00202	0.00445	CcSEcCtD
Trandolapril—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00201	0.00442	CcSEcCtD
Trandolapril—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00195	0.00429	CcSEcCtD
Trandolapril—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00194	0.00427	CcSEcCtD
Trandolapril—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00194	0.00427	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00191	0.00655	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00191	0.00655	CbGpPWpGaD
Trandolapril—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00181	0.00398	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00178	0.00609	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00178	0.00609	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00178	0.00608	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00178	0.00608	CbGpPWpGaD
Trandolapril—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00176	0.00387	CcSEcCtD
Trandolapril—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00174	0.00382	CcSEcCtD
Trandolapril—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00168	0.00369	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00165	0.00565	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00165	0.00565	CbGpPWpGaD
Trandolapril—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00162	0.00357	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00159	0.00543	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00159	0.00543	CbGpPWpGaD
Trandolapril—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00343	CcSEcCtD
Trandolapril—Rash—Hydrochlorothiazide—nephrolithiasis	0.00155	0.0034	CcSEcCtD
Trandolapril—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00155	0.0034	CcSEcCtD
Trandolapril—Headache—Hydrochlorothiazide—nephrolithiasis	0.00154	0.00338	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00147	0.00504	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00147	0.00504	CbGpPWpGaD
Trandolapril—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00146	0.00321	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00127	0.00434	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00118	0.00403	CbGpPWpGaD
